The Georgia Poison Center has received 315 calls involving kratom-like products, including synthetic kratom, and reported ...

The rate of opioid use disorder diagnoses among commercially insured patients rose 32.7% nationwide between 2022 and 2025, ...

Atrium Health invest 340M to expand behavioral health services with a new hospital, adding 168 beds and enhancing crisis care ...

Adults with schizophrenia and Type 2 diabetes who started a glucagon-like peptide-1 receptor agonist were less likely to be ...

The Washington Poison Center warned the public Oct. 6 that some supplements sold as cat’s claw are counterfeit products ...

Nebraska’s Department of Health and Human Services has proposed eliminating 38 beds across two state psychiatric hospitals ...

The National Labor Relations Board has issued a consolidated complaint against Rogers Memorial Hospital, which operates as ...

Michigan regulators are seeking to revoke the license of Kalamazoo (Mich.) Behavioral Health Hospital, which is owned by ...

The Drug Enforcement Administration is monitoring emerging threats from potent synthetic substances, including nitazenes and ...

Pittsburgh-based UPMC Western Psychiatric Hospital ranked No. 7 on U.S. News & World Report’s 2026-27 Best Hospitals for ...

The Texas Health and Human Services Commission has proposed cutting all funding for the Children’s Autism Program in its 2028 ...

Evidence is growing that GLP-1 receptor agonists, the drugs best known for treating diabetes and obesity, could also have a ...